Highly active antiretroviral therapy offers similar benefit to HIV-infected injection drug users

published on August 6, 2008 in NewsPostOnline

Washington, Aug 4 (ANI): New research from the University of British Columbia and St. Paul’’s Hospital, Vancouver, Canada, suggests that highly active antiretroviral therapy (HAART) can be as beneficial for HIV-infected injection drug users (IDUs) as for non-users.

The new finding counters the belief that HIV infected IDUs were less likely to benefit from HAART.

During the study, the researchers found little difference in the survival rate between IDUs and non-IDUs after 4-5 years of receiving the treatment.

Since the mid-1990s, significant reductions have been observed in illness and death related to the human immunodeficiency virus (HIV) among patients receiving HAART. More >>

View the full article >>

Tags:

HIV Clinical Care

Julio Montaner

Our work serves clients and communities across British Columbia on lands and waters cared for and nurtured by the many distinct First Nations across the province. The BC-CfE humbly and gratefully acknowledge the stewards of these lands, particularly the xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and səl̓ílwətaʔ (Tsleil-Waututh) on whose unceded, traditional and ancestral territories our offices are located.

© Copyright BC Centre for Excellence in HIV/AIDS
St. Paul's Hospital 608–1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
Tel: 604-806-8477 | Fax: 604-806-9044
General inquiries: info@bccfe.ca
Media inquiries: communications@bccfe.ca
(Please do not use any of these email addresses to send personal information or book an appointment. To book appointments or contact the H2H clinic, please call 604-416-1517 or fax: 604-564-4893. Do not send your or your client's personal information via email.)

BC Centre for Excellence in HIV/AIDS

Search form

Highly active antiretroviral therapy offers similar benefit to HIV-infected injection drug users

Search form